U
Umed
Biotech & Life Sciences · London, United Kingdom · Founded 2018
A technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries MoreLess
uMed is a healthcare technology company that accelerates medical research by building consented patient cohorts and generating real-time clinical data insights. The company serves life science companies, healthcare professionals, and patients. Operating in the medical research and healthcare sectors, uMed's business model focuses on creating unique, exclusive data that meets specific research requirements. This data is generated by integrating clinical outcomes from deeply characterized patient cohorts. uMed makes money by providing these valuable data insights and research capabilities to its clients. The company also empowers patients to participate in relevant medical research opportunities from the comfort of their homes, while healthcare professionals benefit from automated processes that reduce their workload and enable participation in more studies.
Keywords: medical research, patient cohorts, clinical data, healthcare technology, life sciences, data insights, patient engagement, research automation, healthcare professionals, real-time data.
Company overview
Umed company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Employees
- 93
- Open positions
- None listed
- Dealroom signal
- 84.6
Valuation & funding
Umed funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2023 | $13M | $52M | Playfair Capital · 11.2 Capital · AlbionVC · Delin Ventures | ↗ |
| SEED✓Equity / VC | Dec 2020 | $4.9M | $20M | 11.2 Capital · Delin Ventures · Playfair Capital · AlbionVC | — |
| SEED✓Equity / VC | Mar 2019 | $660K | $2.6M | Playfair Capital | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $8.8M | 0% | 93 |
| 2025 | $8.8M | 0% | 63 |
| 2024 | $8.8M | 0% | 63 |
| 2023 | $8.8M | +191.7% | 89 |
| 2022 | $3M | 0% | 30 |
| 2021 | $3M | +185.7% | 30 |
| 2020 | $1.1M | — | 15 |
Growth signals
Umed website traffic
Latest recorded traffic for Umed is 9.1K monthly website visits, up 1795.8% over the last three months. Umed's team grew 47.6% over the past year.
Comparisons
Umed compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Umed's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Umed's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Umed has talent and traffic
team presence
In the news
Latest news about Umed
Recent press, funding announcements, and product moves mentioning Umed — open to read from the original sources.
Market sentiment
What the market is saying about Umed
An AI-synthesized read of the highest-engagement posts about Umed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Umed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.